MedPage Today on MSN
Year in Review: Alzheimer's Disease
News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...
New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...
Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...
Two major clinical trials evaluating the potential of the weight-loss drug semaglutide to treat Alzheimer’s disease have ...
Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...
The actor’s National Geographic documentary shows the power of memory and social connection in supporting his father’s ...
FOX 32 Chicago on MSN
How to spot signs of Alzheimer's disease in a loved one
Choose a calm moment, listen first and give the person time to share how they feel. Here are some other tips on how to help a ...
1don MSNOpinion
Novo Nordisk slides as Ozempic pill fails to slow Alzheimer’s disease progression in large trials
Novo Nordisk (NVO) fell nearly 10% in U.S. premarket trading on Monday after the Danish drugmaker said a pill version of ...
In people at risk for Alzheimer’s disease, researchers linked minimal to moderate physical activity to a 3-to 7-year delay in cognitive symptoms.
InsideNoVa on MSN
UVA discovers why Alzheimer’s patients forget family and friends
One of the most devastating moments for family members of a patient with Alzheimer’s is when their loved one forgets who they ...
Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results